The long awaited global review on antimicrobial resistance by economist Lord Jim O’Neill has been published....
Up To Date
Latest News
Bayer is deepening its involvement in CRISPR with a licensing agreement for genome editing patents. Irish...
Newly spun out company OxStem has raised £16.9m (€21.5m) to develop regenerative meds for the treatment of...
Swiss Genentech partner AC Immune has raised CHF42.7m (€38.6m) in order to advance its therapeutic and...
Ipsen is strengthening its ties to long-time development partner Oncodesign, a Dijon-based cancer treatment...
Swiss bank Group UBS has raised US$471m (€412m) for the UBS Oncology Impact Fund, which was set up to invest...